Skip to content
healthcare.dev

Carisoprodol Tablets, USP, 350 mg

NDC 63561-0127, Carisoprodol, tablet, from Granulation Technology, Inc..

Product NDC
63561-0127
Status
Listed
Labeler
Granulation Technology, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211789
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0127 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARISOPRODOL350 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
63561-0127-163561012701100 TABLET in 1 BOTTLE, PLASTIC (63561-0127-1)
63561-0127-2635610127021000 TABLET in 1 BOTTLE, PLASTIC (63561-0127-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2abd11e4-8ce4-4aeb-87c4-3af94c197714
  • NADAC price for package 63561012701

    GET /v1/drugs/nadac/63561012701
  • NADAC price for package 63561012702

    GET /v1/drugs/nadac/63561012702

Use it

Look up 63561-0127 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0127 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63561-0127. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.